ホーム > 市場調査レポート > 医薬品

ワクチン

市場調査レポート

商品コード

1741151

細菌ワクチン市場：ワクチンタイプ別、患者年齢層別、投与経路別、販売チャネル別、地域別

Bacterial Vaccines Market, By Vaccine Type, By Patient Age Group, By Route of Administration, By Distribution Channel, By Geography

出版日: 2025年03月26日
発行: Coherent Market Insights
ページ情報: 英文 170 Pages
納期: 2～3営業日

カスタマイズ可能

全表示
概要
目次

概要

サンプル依頼リストに入れる

細菌ワクチン市場は、2025年には277億2,000万米ドルと推定され、2032年には475億1,000万米ドルに達すると予測され、2025年から2032年にかけてCAGR8％で成長すると予測されます。

レポート範囲		レポート詳細
基準年	2024	2025年の市場規模	277億2,000万米ドル
実績データ	2020年から2024年まで	予測期間	2025年から2032年
予測期間：2025年～2032年 CAGR：	8.00%	2032年の価値予測	475億1,000万米ドル

細菌ワクチンには、免疫系を活性化させる弱毒または死菌が含まれています。これは、結核、コレラ、炭疽、インフルエンザ、破傷風、髄膜炎、腸チフスなどの感染症と闘うための予防医学に不可欠な方法です。政府や非政府組織は、感染症に対するワクチンを含む予防薬の利点についての認識を広めるために、いくつかのプログラムを実施しています。

市場力学：

世界の細菌ワクチン市場は、予測期間中に大幅な成長が見込まれます。これは主に、致死的な感染症に対する予防薬を世界中の人々が確実に利用できるようにするため、世界中の政府が重要なイニシアチブを取っているためです。また、パンデミック時の予防接種需要の増加も市場を後押ししています。さらに、感染症に対する新しいデオキシリボ核酸（DNA）ワクチンの発売が市場を牽引しています。COVID-19パンデミックは、様々なDNAワクチンの開発に影響を与え、細菌ワクチン市場の成長にプラスの影響を与えています。抗生物質耐性の細菌性疾患の発生率の上昇が、細菌ワクチン市場の成長を再び促進しています。このことは、主要市場プレーヤーが感染症に対するより効果的なワクチンの開発に注力し、研究活動に投資することに影響を与えています。

しかし、細菌性疾患に関する認識不足が細菌ワクチン市場の成長を妨げると予想されています。

例えば、英国政府は2023年9月28日、バーミンガム大学主催の細菌ワクチンネットワーク（BactiVac）に140万米ドルの資金を提供し、抗菌薬耐性（AMR）との世界の戦いの一環として、感染症の発生を予防するための細菌ワクチンの開発を加速させることを決定しました。細菌ワクチンは、感染症の発症を予防し、抗菌薬使用の必要性を減らすことで、AMRとの闘いにおいて重要な役割を果たします。

本調査の主な特徴

本レポートは、世界の細菌ワクチン市場を詳細に分析し、2024年を基準年として、2025年から2032年までの予測期間における市場規模および複合年間成長率（CAGR）を提供します。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の細菌ワクチン市場の主要企業プロファイルを掲載しています。
本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
細菌ワクチンの世界市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
利害関係者は、世界の細菌ワクチン市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

Company Profie
- GSK plc
- Pfizer Inc.
- Merck & Co., Inc.
- Sanofi
- Johnson & Johnson Service, Inc.
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech
- Biological E. Limited
- Astellas Pharma Inc.
- Seqirus（CSL Limited）
- AstraZeneca
- Novavax, Inc.
- Bavarian Nordic A/S
- Emergent BioSolutions Inc.
- Valneva SE
- Takeda Pharmaceutical Company Limited
- Boehringer Ingelheim International GmbH
- Immunomic Therapeutics, Inc.
- Moderna, Inc.
- Clover Biopharmaceuticals
- Analysts'Views

第11章セクション

参考文献
調査手法
出版社について

Product Code: CMI5877

Bacterial Vaccines Market is estimated to be valued at USD 27.72 Bn in 2025 and is expected to reach USD 47.51 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 27.72 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.00%	2032 Value Projection:	USD 47.51 Bn

Bacterial vaccines contain mild or killed forms of bacteria that activate the immune system. This is a vital method for preventive medicine to fight infections like tuberculosis, cholera, anthrax, influenza, tetanus, meningitis, and typhoid. Several programs are carried out by governments and non-governmental organizations to spread awareness about the benefits of the preventive medicines including vaccines against infectious diseases.

Market Dynamics:

Global bacterial vaccines market is expected to grow at a substantial rate during the forecast period. This is mainly due to significant initiatives undertaken by governments across the globe to ensure that the preventive medicine for lethal infectious diseases is available for the population across the world. The market is also fueled by the increasing demand for vaccinations during pandemics. Moreover, the market is driven by the launch of new Deoxyribonucleic acid (DNA) vaccines against infectious diseases. The Covid-19 pandemic has influenced the development of a variety of DNA vaccines and hence positively impacted the growth of the bacterial vaccines market. The rising incidence of antibiotic-resistant bacterial diseases is again driving the growth of bacterial vaccines market. This is influencing the key market players to invest in research activities by focusing on developing more effective vaccines against infectious diseases.

However, lack of awareness regarding the bacterial disease is expected to hinder the market growth of the bacterial vaccines

For instance, on September 28, 2023, the U.K. government awarded the University of Birmingham-hosted Bacterial Vaccines Network (BactiVac) US$ 1.4 million in funding to accelerate the development of bacterial vaccines in a bid to prevent infections from occurring as part of the global fight against antimicrobial resistance (AMR). Bacterial vaccines play a critical role in the fight against AMR, both through preventing infections from developing and reducing the need to use antimicrobials.

Key features of the study:

This report provides in-depth analysis of the global bacterial vaccines market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global bacterial vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GSK plc., Pfizer Inc., Merck & Co., Inc., Sanofi, Johnson & Johnson Service, Inc., Serum Institute of India Pvt. Ltd., Bharat Biotech Biological E. Limited, Astellas Pharma Inc., Seqirus (CSL Limited), AstraZeneca, Novavax, Inc., Bavarian Nordic A/S, Emergent BioSolutions Inc., Valneva SE, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Immunomic Therapeutics, Inc., Moderna, Inc., Clover Biopharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global bacterial vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacterial vaccines market

Global Bacterial Vaccines Market Detailed Segmentation:

By Vaccine Type
- Pertussis (Whooping Cough) Vaccines
- Tetanus Vaccines
- Diphtheria Vaccines
- Pneumococcal Vaccines
- Meningococcal Vaccines
- Typhoid Vaccines
- Tuberculosis (TB) Vaccines
- Cholera Vaccines
- Shigellosis Vaccines
- Others
By Patient Age Group
- Pediatric Vaccines (Infants, Children)
- Adolescent Vaccines
- Adult Vaccines
- Geriatric Vaccines
By Route of Administration
- Intramuscular
- Intravenous
- Subcutaneous
- Others (Oral, Nasal among others)
By Distribution Channel
- Public
- Private
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profile
- GSK Plc
- Pfizer Inc.
- Merck & Co., Inc.
- Sanofi
- Johnson & Johnson Service, Inc.
- Serum Institute of India Pvt. Ltd.
- Bharat Biotech
- Biological E. Limited
- Astellas Pharma Inc.
- Seqirus (CSL Limited)
- AstraZeneca
- Novavax, Inc.
- Bavarian Nordic A/S
- Emergent BioSolutions Inc.
- Valneva SE
- Takeda Pharmaceutical Company Limited
- Boehringer Ingelheim International GmbH
- Immunomic Therapeutics, Inc.
- Moderna, Inc.
- Clover Biopharmaceuticals

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Vaccine Type
- Market Snippet, By Patient Age Group
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraints
- Opportunities
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions, and Collaborations

4. Global Bacterial Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Bacterial Vaccines Market, By Vaccine Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pertussis (Whooping Cough) Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Tetanus Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Diphtheria Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Pneumococcal Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Meningococcal Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Typhoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Tuberculosis (TB) Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cholera Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Shigellosis Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Bacterial Vaccines Market, By Patient Age Group, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric Vaccines (Infants, Children)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Adolescent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Adult Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Geriatric Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Bacterial Vaccines Market, By Route of Administration, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Bacterial Vaccines Market, By Distribution Channel, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Bacterial Vaccines Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021 -2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Age Group, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Company Profie
- GSK plc
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Sanofi
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Johnson & Johnson Service, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Serum Institute of India Pvt. Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Bharat Biotech
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Biological E. Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Astellas Pharma Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Seqirus (CSL Limited)
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- AstraZeneca
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Novavax, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Bavarian Nordic A/S
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Emergent BioSolutions Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Valneva SE
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Takeda Pharmaceutical Company Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Boehringer Ingelheim International GmbH
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Immunomic Therapeutics, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Moderna, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Clover Biopharmaceuticals
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Analysts' Views

11. Section

References
Research Methodology
About us

細菌ワクチン市場：ワクチンタイプ別、患者年齢層別、投与経路別、販売チャネル別、地域別

Bacterial Vaccines Market, By Vaccine Type, By Patient Age Group, By Route of Administration, By Distribution Channel, By Geography

全表示

市場力学：

本調査の主な特徴

目次

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の細菌ワクチン市場- コロナウイルス（COVID-19）パンデミックの影響

第5章世界の細菌ワクチン市場、ワクチンタイプ別、2020年～2032年

第6章世界の細菌ワクチン市場、患者年齢層別、2020年～2032年

第7章世界の細菌ワクチン市場、投与経路別、2020年～2032年

第8章世界の細菌ワクチン市場、流通チャネル別、2020年～2032年

第9章世界の細菌ワクチン市場、地域別、2020年～2032年

第10章競合情勢

第11章セクション

Market Dynamics:

Key features of the study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Bacterial Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Bacterial Vaccines Market, By Vaccine Type, 2020-2032, (US$ Bn)

6. Global Bacterial Vaccines Market, By Patient Age Group, 2020-2032, (US$ Bn)

7. Global Bacterial Vaccines Market, By Route of Administration, 2020-2032, (US$ Bn)

8. Global Bacterial Vaccines Market, By Distribution Channel, 2020-2032, (US$ Bn)

9. Global Bacterial Vaccines Market, By Region, 2020-2032, (US$ Bn)

10. Competitive Landscape

11. Section

細菌ワクチン市場：ワクチンタイプ別、患者年齢層別、投与経路別、販売チャネル別、地域別

Bacterial Vaccines Market, By Vaccine Type, By Patient Age Group, By Route of Administration, By Distribution Channel, By Geography

全表示

市場力学：

本調査の主な特徴

目次

第1章 調査の目的と前提条件

第2章 市場の展望

第3章 市場力学、規制、動向分析

第4章 世界の細菌ワクチン市場- コロナウイルス（COVID-19）パンデミックの影響

第5章 世界の細菌ワクチン市場、ワクチンタイプ別、2020年～2032年

第6章 世界の細菌ワクチン市場、患者年齢層別、2020年～2032年

第7章 世界の細菌ワクチン市場、投与経路別、2020年～2032年

第8章 世界の細菌ワクチン市場、流通チャネル別、2020年～2032年

第9章 世界の細菌ワクチン市場、地域別、2020年～2032年

第10章 競合情勢

第11章 セクション

Market Dynamics:

Key features of the study:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Bacterial Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Bacterial Vaccines Market, By Vaccine Type, 2020-2032, (US$ Bn)

6. Global Bacterial Vaccines Market, By Patient Age Group, 2020-2032, (US$ Bn)

7. Global Bacterial Vaccines Market, By Route of Administration, 2020-2032, (US$ Bn)

8. Global Bacterial Vaccines Market, By Distribution Channel, 2020-2032, (US$ Bn)

9. Global Bacterial Vaccines Market, By Region, 2020-2032, (US$ Bn)

10. Competitive Landscape

11. Section

第1章調査の目的と前提条件

第2章市場の展望

第3章市場力学、規制、動向分析

第4章世界の細菌ワクチン市場- コロナウイルス（COVID-19）パンデミックの影響

第5章世界の細菌ワクチン市場、ワクチンタイプ別、2020年～2032年

第6章世界の細菌ワクチン市場、患者年齢層別、2020年～2032年

第7章世界の細菌ワクチン市場、投与経路別、2020年～2032年

第8章世界の細菌ワクチン市場、流通チャネル別、2020年～2032年

第9章世界の細菌ワクチン市場、地域別、2020年～2032年

第10章競合情勢

第11章セクション